D. Sadlier

C. L. le Roux, F. Tam, D. Sadlier, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Early viral and peripheral blood mononuclear cell responses to pegylated interferon and ribavirin treatment: the first 24 h

J. Crowe, M. Lawless, J. Browne, 2010, European journal of gastroenterology & hepatology.

The effect of obesity on acute kidney injury after cardiac surgery.

D. Sadlier, J. Byrne, K. O’Sullivan, 2015, The Journal of thoracic and cardiovascular surgery.

Evidence for a Causal Role of Obesity in Diabetic Kidney Disease.

J. Hirschhorn, J. Florez, C. Forsblom, 2015 .

DNA methylation profiling in cell models of diabetic nephropathy

E. Brennan, D. Brazil, A. Maxwell, 2010, Epigenetics.

Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.

M. Kretzler, F. Martin, H. Schmid, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: Implications for the pathogenesis of diabetic nephropathy

D. Brazil, D. Sadlier, C. Godson, 2011, FEBS letters.

No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.–1504C>T and c.–546C>G with diabetic nephropathy in Type 1 diabetes

A. Maxwell, C. Patterson, D. Sadlier, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Pro-resolving lipid mediators: Agents of anti-ageing?

D. Sadlier, C. Godson, Denise M Sadlier, 2018, Seminars in immunology.

Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1.

E. Brennan, K. Nolan, A. Maxwell, 2013, Journal of the American Society of Nephrology : JASN.

Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy.

Melissa J. Morine, C. Cohen, E. Brennan, 2012, Biochimica et biophysica acta.

Chapter 40 – Recurrent and De Novo Renal Diseases After Kidney Transplantation

D. Sadlier, Y. O’Meara, 2010 .

Chapter 39 – Recurrent and De Novo Renal Disease in Kidney Transplantation

D. Sadlier, Y. O’Meara, 2005 .

The Kilkenny integrated Oral Health Project

D. Sadlier, M. Hobdell, B. Daly, 1991, Irish Journal of Medical Science.

Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease

J. Hirschhorn, J. Florez, C. Forsblom, 2022, Nature communications.

Sequential Extracellular Matrix-focused and Baited-global Cluster Analysis of Serial Transcriptomic Profiles Identifies Candidate Modulators of Renal Tubulointerstitial Fibrosis in Murine Adriamycin-induced Nephropathy*

D. Harris, D. Brazil, D. Sadlier, 2004, Journal of Biological Chemistry.

A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer

P. Macmathuna, D. Sadlier, P. Doran, 2011, BMC Cancer.

LUNG TISSUE STORAGE: OPTIMIZING CONDITIONS FOR FUTURE USE IN MOLECULAR RESEARCH

C. Hurson, J. Egan, D. Sadlier, 2008, Experimental lung research.

A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.

B. McNicholas, D. Kavanagh, D. Sadlier, 2012, Blood.

Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease

J. Hirschhorn, J. Florez, C. Forsblom, 2015, Diabetes.

Resequencing of genes for transforming growth factor β1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy

A. McKnight, A. Maxwell, C. Patterson, 2007, BMC Medical Genetics.

A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy.

A. McKnight, A. Maxwell, C. Patterson, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.

J. Hirschhorn, J. Tuomilehto, J. Florez, 2013, Journal of the American Society of Nephrology : JASN.

Diagnostic utility of genetic testing in patients undergoing renal biopsy

G. Cavalleri, E. Brennan, D. Sadlier, 2020, Cold Spring Harbor molecular case studies.

Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells.

D. Sadlier, C. Godson, K. Rodgers, 2005, The American journal of pathology.

Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritis.

T. Nakagawa, D. Sadlier, C. Godson, 2005, Kidney international.

Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic Nephropathy

J. Hirschhorn, J. Tuomilehto, J. Florez, 2012, Diabetes.

Regulation and consequences of differential gene expression in diabetic kidney disease.

D. Brazil, F. Martin, D. Sadlier, 2008, Biochemical Society transactions.

Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus

A. Maxwell, D. Sadlier, J. Kilner, 2010, Diabetic medicine : a journal of the British Diabetic Association.

Original Article: Genetics Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus

A. McKnight, A. Maxwell, C. Patterson, 2010 .

Chromosome 2 q 31 . 1 Associates with ESRD in Women with Type 1 Diabetes

J. Hirschhorn, J. Tuomilehto, J. Florez, 2013 .

Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic

S. Ennis, D. Sadlier, W. Cullen, 2021, Frontiers in Medicine.

Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer

D. Fitzgerald, E. Kay, T. Neilan, 2009, British Journal of Cancer.

Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis

C. Hurson, J. Butler, D. Sadlier, 2007, BMC musculoskeletal disorders.

Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies

A. Lázaro, J. Egido, D. Sadlier, 2009, Hypertension Research.

Transcriptome profiling and the pathogenesis of diabetic complications.

D. Sadlier, P. Doran, H. Brady, 2003, Journal of the American Society of Nephrology : JASN.

Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes

A. Maxwell, D. Sadlier, D. Currie, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines

E. Brennan, A. McKnight, D. Brazil, 2009, Epigenetics.

Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy

P. Deloukas, P. Whittaker, J. Morrison, 2008, Diabetologia.

Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic Nephropathy

Cameron D. Palmer, J. Tuomilehto, J. Florez, 2011, Diabetes.

Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy.

A. McKnight, A. Maxwell, D. Sadlier, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A GREM1 gene variant associates with diabetic nephropathy.

A. McKnight, A. Maxwell, C. Patterson, 2010, Journal of the American Society of Nephrology : JASN.

Bmc Medical Genetics Resequencing of Genes for Transforming Growth Factor Β1 (tgfb1) Type 1 and 2 Receptors (tgfbr1, Tgfbr2), and Association Analysis of Variants with Diabetic Nephropathy

A. Maxwell, D. Sadlier, D. Savage, 2022 .

Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes

A. McKnight, D. Sadlier, D. Currie, 2008, Diabetic medicine : a journal of the British Diabetic Association.